HOME >> BIOLOGY >> NEWS
Chest compression device outperforms manual CPR

A battery-operated compression belt buckled around the chest restores blood flow better than manual chest compressions and conventional CPR, according to a Johns Hopkins-led animal study.

The device, which resembles an eight-inch wide seat belt, is buckled around the chest, tightened and motorized. Once switched on, it contracts against the chest, stimulating blood flow.

Researchers who tested the device on 20 pigs in cardiac arrest found that it restored blood flow four times better than manual compressions and returned the hearts to pre-arrest condition. Results of the study, supported by Revivant Corp., are to be presented Nov. 19 at the American Heart Association's 75th annual Scientific Sessions in Chicago.

"The key to restoring viability is to wash out the waste and move oxygenated blood to the vital organs," says Henry R. Halperin, M.D., lead author of the study and professor of medicine and biomedical engineering at Hopkins. "The belt can compress a greater area of the chest than manual compressions, so it restores more blood flow than manual CPR. Wherever a health care professional would do manual CPR, a device like this could be better for the patient."

Researchers induced ventricular fibrillation, an electrical abnormality in the heart that precedes cardiac arrest, in the pigs. They then performed both manual cardiopulmonary resuscitation and CPR using the belt device, in random order, and measured blood pressure and flow before and after injecting the pigs with epinephrine, a hormone that constricts small blood vessels.

About 350,000 people each year suffer sudden cardiac arrest, 95 percent of whom die; most require defibrillation. Defibrillators are most effective if used within the first two minutes of arrest, Halperin says, but most attacks occur at home. It can take an average of six to eight minutes for paramedics to arrive, he says, and defibrillation is often unsuccessful at th
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
19-Nov-2002


Page: 1 2

Related biology news :

1. Chestnut trees to spread across landscape again, says Purdue scientist
2. Chestnuts used chemicals to dominate southern Appalachian forests
3. Can exercise before diving prevent decompression sickness?
4. Decompression is a gas
5. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
6. University of Pittsburgh medical center among first to implant heart assist device
7. University of Pittsburgh receives NIH funding to develop heart assist device for infants
8. New database aids medical device exporters
9. Ancient Greeks help scientists build environmentally friendly nano devices
10. Tanning devices - Fast track to skin cancer?
11. New device can help defend against novel biological agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
(Date:12/2/2016)...   SoftServe , a global digital technology ... electrocardiogram (ECG) biosensor analysis system for continuous driver ... The smart system ensures device-to-device communication between ECG ... mobile devices to easily ,recognize, and monitor users ... technology advances, so too must the security systems ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion matches ... Reading ... DERMALOG ... of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... Opal ... provide essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the ... FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single ... engineered to radically streamline culture processes, minimize processing time, significantly decrease production ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
Cached News: